Data from The Leapfrog Group shows hospitals are reducing healthcare-associated infections (HAIs) that spiked during COVID-19, with 19% reporting lower infection ratios for the three commonly tracked HAIs and 66% improving at least one. However, patient reports about their health care experience are said to continue declining despite the improvements.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
